Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.
Notably, those who received nivolumab exhibited higher rates of hepatitis B surface antigen (HBsAg) loss compared to other groups. This is seen as a significant step forward in targeting HBsAg ...
HBV reactivation (HBVr) occurs when HBV activity is no longer suppressed by the immune system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).
We similarly followed 16 children of hepatitis B surface antigen (HBsAg)-positive mothers. Results: Of low risk infants receiving a plasma-derived vaccine, 41% (42 of 102) of those whose primary ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
Antibody concentrations ≥10mIU/mL against HBsAg are recognized as conferring protection against hepatitis B virus infection. Give IM in deltoid muscle. 11–19yrs: 10mcg at elected date and ...